Observational studyFrontiers in endocrinology2026
Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes.
Wancheng Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.